A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Rosalio Madrigal
Tudor Pop
Rosalio Madrigal
Rosalio Madrigal
Rosalio Madrigal
| Share Statistics | AZN | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $246,254.3 | $519.2 | 99% |
|
| Shares Out (Mil) | 1,560.0 | 42.8 | 96% |
|
| Institutional Ownership | 99.9% | 82.8% | 96% |
|
| Float (Mil) | 1,542.9 | 44.4 | 94% |
|
| Beta | 0.21 | 0.71 | 13% |
|
| Avg Daily Volume (000s) | 2,605 | 394 | 85% |
|
| Price Change (52-week) |
6.3% | 60.2% | 59% |
|
| Growth | AZN | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | 17.2% | 6.1% | 77% |
|
| Net Income (5yr) | 26.2% | (2.0%) | 81% |
|
| EPS (5yr) | 21.8% | 15.0% | 71 |
|
| Dividends (5yr) | 2.7% | 0.0% | 95% |
|
| Cash Flow (5yr) | (37.4%) | (15.1%) | 13% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | 3 | 3 | |
| Current EPS | $1.146 | $10.047 | $11.323 | |
| Month Ago EPS | $2.685 | $10.453 | $11.428 | |
| # Rev Up | 1 | 1 | 1 | |
| # Rev Down | 0 | 1 | 2 | |
| Three Months Ago EPS | $2.675 | $10.407 | $11.507 | |
| Year/Year Chg | (28.8%) | 53.6% | 92.0% | |
| Financials | AZN | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | $61,366 | $416 | 97% |
|
| Net Income (TTM) (Mil) | $10,446 | ($11) | 99% |
|
| EPS (TTM) | $6.739 | ($0.700) | 90% |
|
| Operating Cash Flow (TTM) (Mil) | $13,700 | ($7) | 98% |
|
| Net Cash Flow (TTM) (Mil) | ($2,148) | $6 | 2% |
|
| Long-Term Debt (Q1) (Mil) | $26,008 | $6 | 96% |
|
| Enterprise Value (Q1) (Mil) | $268,698 | $494 | 99% |
|
| Valuation | AZN | Industry Median |
Percentile (All Stocks) |
|
| P/B | 4.91 | 2.31 | 79% |
|
| P/E | 23.8 | 17.4 | 62% |
|
| Dividend Yield | 1.5% | 0.0% | 72% |
|
| PEG (5yr hist) | 1.1 | 1.1 | 50% |
|
| Ratios | AZN | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | 81.7% | 69.4% | 90% |
|
| Net Margin | 17.0% | 3.2% | 75% |
|
| ROA | 9.2% | (22.2%) | 85% |
|
| ROE | 22.0% | (21.4%) | 82% |
|
| Liabilities to Assets | 56.5% | 32.8% | 50% |
|
| F-Score | 7 | 3 | 82% |
|
AstraZeneca PLC did not pass any screens on 10/9/2026.
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors
